| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002) (NCT00635804) | Merck Sharp & Dohme LLC | 2008-02-19 |
| Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C (NCT00638144) | University Hospital, Strasbourg, France | 2008-02-01 |
| An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection (NCT00580801) | Tibotec BVBA | 2008-01-01 |
| Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C (NCT00621296) | Tanabe Pharma Corporation | 2008-01-01 |
| Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C (NCT00593151) | Biolex Therapeutics, Inc. | 2008-01-01 |
| The Effect of Adding Metformin to the Treatment of Hepatitis C (NCT00560690) | Tehran University of Medical Sciences | 2007-12-01 |
| Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209) (NCT00724464) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Pegaferon and Ribavirin for Hepatitis C (NCT01137383) | Tehran University of Medical Sciences | 2007-12-01 |
| A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy (NCT00535847) | Vertex Pharmaceuticals Incorporated | 2007-10-01 |
| Directly Observed Hepatitis C Treatment in Methadone Clinics (NCT01442311) | Albert Einstein College of Medicine | 2007-10-01 |
| Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients (NCT00728936) | Idera Pharmaceuticals, Inc. | 2007-09-01 |
| Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients (NCT00527774) | St. Martin De Porress Hospital | 2007-09-01 |
| Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals (NCT00393276) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-08-01 |
| Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life (NCT02943330) | Chang Gung Memorial Hospital | 2007-08-01 |
| Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C (NCT00512278) | Nizar Zein | 2007-07-01 |
| Ribavirin, Its Dosing Regime (NCT00484328) | Maastricht University Medical Center | 2007-07-01 |
| Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED) (NCT00518622) | Merck Sharp & Dohme LLC | 2007-07-01 |
| Hepatitis C Self-Management (NCT00328042) | US Department of Veterans Affairs | 2007-05-01 |
| Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1) (NCT01025596) | Cytheris SA | 2007-05-01 |
| Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens (NCT00470210) | Germans Trias i Pujol Hospital | 2007-05-01 |
| Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection (NCT00707850) | Baqiyatallah Medical Sciences University | 2007-05-01 |
| Effective Treatment of Hepatitis C in Substance Users (NCT00633243) | Yale University | 2007-04-01 |
| Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection (NCT00707772) | Baqiyatallah Medical Sciences University | 2007-03-01 |
| Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy (NCT00437684) | IRCCS San Raffaele | 2007-02-01 |
| Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C (NCT00527540) | Tehran Hepatitis Center | 2007-02-01 |
| A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3) (NCT00420784) | Vertex Pharmaceuticals Incorporated | 2007-02-01 |
| Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin (NCT00456248) | Kadmon Corporation, LLC | 2007-02-01 |
| Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy (NCT00437476) | IRCCS San Raffaele | 2007-02-01 |
| TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing (NCT00938899) | Tibotec Pharmaceuticals, Ireland | 2007-01-01 |
| Overcoming Psychiatric Barriers to the Treatment of Hepatitis C (NCT00407732) | University of North Carolina, Chapel Hill | 2007-01-01 |
| A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients (NCT00445315) | Pfizer | 2007-01-01 |
| Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. (NCT00422838) | Foundation for Liver Research | 2007-01-01 |
| Characterization of Clonal B Cell Populations in HCV Infection (NCT00435201) | Rockefeller University | 2007-01-01 |
| Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical Trial (NCT00983164) | Universidade do Sul de Santa Catarina | 2007-01-01 |
| Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C (NCT00446940) | Bader, Ted, M.D. | 2006-12-01 |
| Mucomyst for Hepatitis C (NCT00493610) | US Department of Veterans Affairs | 2006-11-01 |
| Trial of Citalopram for the Prevention of Depression (NCT00317746) | Marina Klein | 2006-11-01 |
| Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging (NCT00401336) | Rennes University Hospital | 2006-11-01 |
| Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults (NCT00439959) | GlaxoSmithKline | 2006-10-01 |
| A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects (NCT00367887) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-10-01 |
| Rosuvastatin for Hepatitis C (NCT00371579) | UMC Utrecht | 2006-10-01 |
| Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD (NCT00333710) | US Department of Veterans Affairs | 2006-09-01 |
| Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) (NCT00381017) | Merck Sharp & Dohme LLC | 2006-09-01 |
| Psychoeducation for Hepatitis and Alcohol Behaviors (NCT00598416) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2006-09-01 |
| Fluvastatin Versus Hepatitis C Virus (NCT00441493) | Bader, Ted, M.D. | 2006-09-01 |
| Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine (NCT00310336) | University Hospital, Basel, Switzerland | 2006-08-01 |
| Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy (NCT00372983) | Cellectar Biosciences, Inc. | 2006-08-01 |
| Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427) (NCT00724854) | Merck Sharp & Dohme LLC | 2006-08-01 |
| BreathID Multi-center HCV Liver Breath Test Study (NCT00350714) | Meridian Bioscience, Inc. | 2006-07-01 |
| Transplant-Related Accelerated Progression of Hepatitis C (NCT00368225) | National Institutes of Health Clinical Center (CC) | 2006-06-22 |
| Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED) (NCT00727077) | Merck Sharp & Dohme LLC | 2006-06-01 |
| Chronic Hepatitis C and Insulin Resistance (NCT00707603) | Garvan Institute of Medical Research | 2006-05-01 |
| Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes (NCT00324389) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Effects of HIV and Hepatitis C Virus on the Brain (NCT00494936) | Icahn School of Medicine at Mount Sinai | 2006-05-01 |
| Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults (NCT00314054) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793) (NCT00709228) | Merck Sharp & Dohme LLC | 2006-05-01 |
| Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C (NCT00343525) | Peregrine Pharmaceuticals | 2006-05-01 |
| Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV (NCT00545558) | University of Cincinnati | 2006-04-01 |
| Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C (NCT01292161) | Isfahan University of Medical Sciences | 2006-03-01 |
| Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690) (NCT00725205) | Merck Sharp & Dohme LLC | 2006-03-01 |
| Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV) (NCT00958763) | University of California, Los Angeles | 2006-03-01 |
| Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED) (NCT00724230) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus (NCT00403533) | Massachusetts General Hospital | 2006-02-01 |
| Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4 (NCT00502099) | Amr Hafez | 2006-01-01 |
| Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus (NCT00260208) | Novartis Pharmaceuticals | 2006-01-01 |
| Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy (NCT00266318) | Beth Israel Medical Center | 2005-12-01 |
| Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584) (NCT00736242) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C (NCT00262483) | Vertex Pharmaceuticals Incorporated | 2005-12-01 |
| Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C (NCT00252642) | Virginia Commonwealth University | 2005-11-01 |
| A Video-Based HCV Curriculum for Drug Users (NCT00241917) | Organization to Achieve Solutions in Substance Abuse (OASIS) | 2005-11-01 |
| A Video-Based HCV Curriculum for Active Injection Drug Users (NCT00241943) | Organization to Achieve Solutions in Substance Abuse (OASIS) | 2005-11-01 |
| Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant (NCT00135694) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C (NCT00141284) | Pfizer | 2005-10-01 |
| VX-950 and Peginterferon for Hepatitis C (NCT00251199) | Vertex Pharmaceuticals Incorporated | 2005-10-01 |
| Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection (NCT00300807) | XTL Biopharmaceuticals | 2005-10-01 |
| Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin (NCT00207402) | Brooke Army Medical Center | 2005-10-01 |
| Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4 (NCT00612755) | Hospital Clinico Universitario San Cecilio | 2005-10-01 |
| Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671) (NCT00728494) | Merck Sharp & Dohme LLC | 2005-10-01 |
| Immune Response to Hepatitis C Virus (NCT00165919) | Emory University | 2005-09-01 |
| Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED) (NCT00723632) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation (NCT00135798) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-09-01 |
| Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301) (NCT00704717) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Risk Assessment of Long-Haul Truck Drivers (NCT00381992) | Wake Forest University Health Sciences | 2005-09-01 |
| Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients (NCT00703560) | University of Texas Southwestern Medical Center | 2005-09-01 |
| Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients (NCT00229749) | Sarepta Therapeutics, Inc. | 2005-09-01 |
| Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus (NCT00207311) | Brooke Army Medical Center | 2005-08-01 |
| Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP) (NCT00150904) | UMC Utrecht | 2005-08-01 |
| Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423) (NCT00724893) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Screening for Hepatitis C During Pregnancy at a Toronto Inner City Prenatal Clinic (NCT00348660) | Unity Health Toronto | 2005-08-01 |
| Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection (NCT00128271) | Peregrine Pharmaceuticals | 2005-08-01 |
| Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C (NCT00917358) | National Taiwan University Hospital | 2005-07-01 |
| Improving Quality of Life for Veterans Undergoing Interferon Treatment (NCT00117559) | US Department of Veterans Affairs | 2005-07-01 |
| Oxidative Stress and Fatty Acids in Hepatitis C (NCT00444002) | Johane Allard | 2005-07-01 |
| Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV (NCT03324633) | ANRS, Emerging Infectious Diseases | 2005-06-01 |
| Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients (NCT00295607) | Astellas Pharma Inc | 2005-06-01 |
| Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED) (NCT00787371) | Merck Sharp & Dohme LLC | 2005-06-01 |
| Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection (NCT00124215) | GlobeImmune | 2005-06-01 |
| Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413) (NCT00704964) | Merck Sharp & Dohme LLC | 2005-05-01 |
| Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505) (NCT00724295) | Merck Sharp & Dohme LLC | 2005-04-01 |
| SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C (NCT00110799) | GlaxoSmithKline | 2005-04-01 |